GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » EBIT per Share

Dannex Ayrton Starwin (XGHA:DASPHARMA) EBIT per Share : GHS (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Dannex Ayrton Starwin EBIT per Share?

Dannex Ayrton Starwin's EBIT per Share for the six months ended in . 20 was GHS0.00. Dannex Ayrton Starwin does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Dannex Ayrton Starwin's EBIT per Share or its related term are showing as below:

XGHA:DASPHARMA's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Dannex Ayrton Starwin's EBIT for the six months ended in . 20 was GHS0.00 Mil.


Dannex Ayrton Starwin EBIT per Share Historical Data

The historical data trend for Dannex Ayrton Starwin's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dannex Ayrton Starwin EBIT per Share Chart

Dannex Ayrton Starwin Annual Data
Trend
EBIT per Share

Dannex Ayrton Starwin Semi-Annual Data
EBIT per Share

Dannex Ayrton Starwin EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Dannex Ayrton Starwin's EBIT per Share for the fiscal year that ended in . 20 is calculated as

EBIT per Share(A: . 20 )
=EBIT/Shares Outstanding (Diluted Average)
=/0
=N/A

Dannex Ayrton Starwin's EBIT per Share for the quarter that ended in . 20 is calculated as

EBIT per Share(Q: . 20 )
=EBIT/Shares Outstanding (Diluted Average)
=/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dannex Ayrton Starwin  (XGHA:DASPHARMA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Dannex Ayrton Starwin EBIT per Share Related Terms

Thank you for viewing the detailed overview of Dannex Ayrton Starwin's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dannex Ayrton Starwin (XGHA:DASPHARMA) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.

Dannex Ayrton Starwin (XGHA:DASPHARMA) Headlines

No Headlines